Crossmark

Attenuated FOLFIRINOX in the salvage treatment of gemcitabine‐refractory advanced pancreatic cancer: a phase II study

Crossref DOI link: https://doi.org/10.1186/s40880-018-0304-1

Published Online: 2018-06-04

Published Print: 2018-12

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Kim, Jung Hoon

Lee, Sang‐Cheol

Oh, Sung Yong

Song, Seo‐Young

Lee, Namsu

Nam, Eun Mi

Lee, Soonil

Hwang, In Gyu

Lee, Hyo Rak

Lee, Kyu Taek

Bae, Sang‐Byung

Kim, Han Jo

Jang, Joung Soon

Lim, Do Hyoung

Lee, Hyun Woo

Kang, Seok Yun

Kang, Jung Hun
Funding

Funding for this research was provided by:

Hanmi Pharmaceutical Co. Ltd.

Soonchunhyang University Research fund
License Information

Version of Record valid from 2018-06-04
More Information

Publication History

Received: 2017-08-05

Accepted: 2018-01-05

Published: 2018-06-04